CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- Open-market buys, last 90 days
- $176,273
- in 1 filing
- Open-market sales, last 90 days
- $13,322,043
- in 2 filings, $1.9M under 10b5-1 plans
Net −$13,145,770. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-20 | Podnos Yale Chief Medical Officer | Returned to the company | −1,026 | $0.14 | $140 | 72,968 |
| 2024-11-12 | Hively Brad Director | Other disposition | −353,450 | 366,753 | ||
| 2024-11-12 | Podnos Yale Chief Medical Officer | Other disposition | −11,359 | 93,009 | ||
| 2024-11-12 | Podnos Yale Chief Medical Officer | Other disposition | −17,039 | 75,970 | ||
| 2024-11-12 | Pacala Mark L Director | Other disposition | −20,248 | 114,781 | ||
| 2024-11-12 | Pacala Mark L Director | Other disposition | −30,372 | 84,409 | ||
| 2024-11-12 | Virnich Daniel Chief Executive Officer | Other disposition | −78,094 | 838,853 | ||
| 2024-11-12 | Virnich Daniel Chief Executive Officer | Other disposition | −117,142 | 721,711 | ||
| 2024-08-16 | Havencrest Healthcare Partners, L.P. 10% owner | Other disposition | −8,701,823 | 7,884,044 | ||
| 2024-08-16 | Havencrest Healthcare Partners, L.P. 10% owner | Other disposition | −7,631,418 | 252,626 | ||
| 2024-06-17 | Hively Brad Director | Returned to the company | −18,121 | $0.46 | $8K | 676,203 |
| 2024-05-22 | Hively Brad Director | Returned to the company | −19,526 | $0.58 | $11K | 694,324 |
| 2024-05-21 | Virnich Daniel Chief Executive Officer | Returned to the company | −11,173 | $0.60 | $7K | 718,430 |
| 2024-05-21 | Virnich Daniel Chief Executive Officer | Grant or award | +198,517 | 916,947 | ||
| 2024-05-21 | Virnich Daniel Chief Executive Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +496,293 | 496,293 | ||
| 2024-05-21 | Shah Mihir Chief Financial Officer | Grant or award | +151,459 | 474,931 | ||
| 2024-05-21 | Shah Mihir Chief Financial Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +378,648 | 378,648 | ||
| 2024-05-21 | Podnos Yale Chief Medical Officer | Grant or award | +17,530 | 104,368 | ||
| 2024-05-21 | Podnos Yale Chief Medical Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +43,825 | 43,825 | ||
| 2024-05-21 | Castle Jeremy Chief Operating Officer | Grant or award | +70,120 | 82,460 |
Page 9 of 18 · 354 trades